• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 34
  • 31
  • 25
  • 5
  • 5
  • 3
  • 1
  • 1
  • 1
  • 1
  • Tagged with
  • 114
  • 114
  • 31
  • 26
  • 22
  • 20
  • 17
  • 14
  • 14
  • 13
  • 12
  • 10
  • 10
  • 9
  • 8
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
31

Signaling specificity in the filamentous growth pathway of Saccharomyces cerevisiae

Romelfanger, Claire Theresa, 1982- 03 1900 (has links)
xii, 41 p. : ill. / Cells convey information through signaling pathways. Distinct signaling pathways often rely on similar mechanisms and may even use the same molecules. With a variety of signals conveyed by pathways that share components, how does the cell maintain the integrity of each pathway? Budding yeast provides an example of multiple signaling pathways utilizing the same components to transduce different signals. The mating pathway, the high osmolarity glycerol (HOG) pathway and the filamentous growth (FG) pathway each respond to different environmental conditions and generate unique cellular responses. Despite the individuality of the pathways, they each contain a core group of the same signaling proteins. How does the cell generate a variety or responses utilizing the same group of proteins? Both the mating and HOG pathways utilize scaffolding factors that concentrate pathway components to the location of activation and in the case of the mating pathway alter the kinetics of the interaction. In addition, negative regulatory mechanisms operate in both the mating and HOG pathways. These negative regulatory mechanisms are understood in detail for the mating pathway but not for the HOG pathway. Mechanisms for providing specificity for the FG pathway are as yet unknown. The purpose of this work is to elucidate the mechanisms that provide specificity to the FG pathway. The search for specificity factors was done through both a random mutagenesis screen and a synthetic genetic array screen, looking for mutants in which activation of the FG pathway led to inappropriate activation of the HOG pathway. The random mutagenesis screen resulted in a large number of mutants that I organized into five complementation groups. The identity of the gene mutated in the largest complementation group was sought using a variety of methods including complementation with the yeast deletion collection and whole genome sequencing. A synthetic genetic array was screened as an alternative method to identify genes necessary for FG pathway specificity. These experiments have resulted in a list of candidate genes, but thus far have not yet led to any discernable mechanism for maintenance of FG pathway specificity. / Committee in charge: Karen Guillemin, Chairperson; George F. Sprague Jr., Advisor; Tom Stevens, Member; Tory Herman, Member; Diane Hawley, Outside Member
32

Substrate Specificity Determinants of Class III Nucleotide Cyclases

Bharambe, Nikhil Govind January 2015 (has links) (PDF)
Cyclic AMP and cyclic GMP (cAMP and cGMP) are important second messengers in key signal-transduction pathways that mediate various physiological functions in bacteria and eukaryotes. Adenylyl Cyclases (ACs) and Guanylyl Cyclases (GCs) cyclize ATP and GTP to produce cAMP and cGMP, respectively. Though most nucleotide cyclises show exquisite specificity for their substrates, there are instances where ACs were observed to have low GC activity as well, and vice versa. To understand structural basis of substrate (ATP or GTP) recognition, discrimination and binding by an adenylyl cyclase, we have taken up Ma1120, an AC from Mycobacterium avium, for our studies. Work presented in the thesis includes crystal structures of Ma1120 in the presence of substrate (ATP or GTP), by-product pyrophosphate and ATP analogue 2′,5′-dideoxyd-3′-adenosine triphosphate (2′,5′-dd-3′-ATP). A triple mutant of Ma1120 (K101→E, D157→G, A167→Y) was generated to increase specificity of Ma1120 towards GTP by mutation in the substrate specifying residues, but the enzyme showed equal specificity for ATP as well as for GTP. Ma1120 exists as a monomer in solution and crystallized as a monomer in the absence of substrate or inhibitor. The substrate specifying lysine residue plays a dual role of interacting with the substrate and stabilizing the dimer. The dimerization loop region harbouring the second substrate specifying residue, an aspartate, shows significant differences in conformation and position between the monomeric and dimeric structures. Thus, this study has not only revealed that significant structural transitions are required for the interconversion of the inactive and the active forms of the enzyme, but also provided precise nature of these transitions. ATP bound to Ma-Cat has two different conformations, one with C2′-endo and the other with C3′-endo puckering for the ribose. C3′-endo conformation is favourable for catalysis as it brings 3′-OH group of ribose and free oxygen of α-phosphate closer to each other. The crystal structure of GTP bound to Ma-Cat showed a novel mode of GTP binding to AC. This is the first report of GTP bound to AC. ATP bound to Ma-Cat-KDA→EGY forms non-cognate substrate complex and ATP is stabilized by stacking of adenines over each other with Tyr167 flanking on both sides of adenines. Ma-Cat-KDA→EGY+GTP complex is the first report of GTP bound to a guanylyl cyclase. GTP is bound in reverse orientation when compared to ATP bound to AC. Reverse orientation of GTP is attained to stabilize the guanine in highly electronegative guanine binding pocket. Also, O3' of GTP is placed in opposite orientation as compared to ATP bound to Ma-Cat. Therefore, during cyclization reaction guanine and ribose changes their orientation to bring O3' atom of ribose closer to α-phosphate, after cleavage of the bond between α- and β-phosphates. Thus, this study has revealed novel modes of binding of ATP and GTP to catalytic domains of Ma1120 and its triple mutant, mechanism of substrate discrimination and residual activity for the non-cognate substrate.
33

Gestion des interférences liées au développement des qualités énergétiques et neuromusculaires / Managing training-induced interferences : energetic workouts and neuromuscular training

Robineau, Julien 20 December 2013 (has links)
La préparation physique du joueur de rugby requière le développement simultané des qualités de force et d’endurance (Duthie et coll., 2003) et nécessite alors la combinaison d’efforts antagonistes pouvant induire un « conflit physiologique » au sein de l’organisme. Hickson (1980) fut le premier chercheur à mettre en évidence que la combinaison des qualités de force et d’endurance, au sein d’une même programmation, semble interférer sur le développement des qualités neuromusculaires. Cette interférence semblerait intervenir préférentiellement sur la production de force à vitesse rapide, la puissance et l’explosivité et concernerait essentiellement les groupes musculaires mobilisés au cours des deux formes d’entraînements. Plusieurs hypothèses, telles que la fatigue et les adaptations physiologiques contradictoires, ont été mises en avant pour expliquer ce phénomène. A l’inverse, l’entraînement de musculation ne semble pas présenter d’effets négatifs sur les adaptations oxydatives. Plusieurs variables, liées à la programmation de l’entraînement, influenceraient l’interférence sur le développement de la force. L’objectif général de ce travail de recherche sera alors d’étudier les effets de différentes configurations d’entraînement permettant de limiter l’intervention du phénomène interférentiel. Dans une première étude, nous avons mis en évidence une fatigue aigue induite par différents types d’entraînements d’endurance de haute intensité pouvant aller jusqu’à 24h. Ces résultats mettaient alors en avant la pertinence de placer les séances qualitatives de force avant celles d’endurance au sein d’une programmation combinée. Dans une deuxième étude, nous avons proposé de vérifier l’effet du temps de récupération entre les séances de force et d’endurance sur les adaptations neuromusculaires et oxydatives. Il s’avérerait alors qu’une durée de récupération de 24h soit plus efficace sur les gains de force et de VO2pic qu’une durée intermédiaire de 6h. Enfin, dans une troisième étude, nous nous sommes centrés sur les effets du type d’entraînement aérobie de haute intensité sur les adaptations physiologiques. L’entraînement de répétition de sprints longs perturberait davantage les gains de force à l’issue d’une période combinée caractérisée pourtant par 24h de récupération entre les séances. Ce type d’entraînement induirait en revanche des gains plus importants de VO2pic et de la performance moyenne au cours d’un test de sprints répétés qu’un entraînement intermittent court. / Physical training of rugby players requires simultaneous development of strength and endurance qualities (Duthie et al., 2003) and therefore the combination of antagonistic exercises inducing a "physiological conflict". Hickson (1980) was the first to demonstrate that the combination of strength and endurance qualities within a same program seems to reduce the development of neuromuscular qualities. This interference would impair preferentially maximal strength production at fast velocity, maximal power and explosivity and would concern mainly muscle groups solicited during the two forms of training (strength and aerobic). Several hypotheses, such as fatigue and conflicting physiological adaptations have been put forward to explain the interference. Conversely, strength training does not appear to have negative effects on oxidative adaptations. Many variables related to schedule of training, would influence the impairment of strength quality development. The main aim of this research was to measure the effects of different configurations of training in order to limit the interference on neuromuscular adaptations. In a first study, we emphasized an acute fatigue up to 24 hours induced by different types of high-intensity interval training. These results showed the relevance to program strength before endurance sessions during a concurrent training program. Then, in a second study, we proposed to measure the effect of recovery delay between strength and aerobic sessions on neuromuscular and oxidative adaptations. We observed a 24h recovery period was more effective than lower duration of 6h on strength gains and VO2peak. Last, in a third study, we focused on the effects of the type of high-intensity interval training. Sprint interval training would more impair strength gains after a concurrent training period, despite 24h recovery delay between sessions. However, this type of training would induce greater gains of VO2peak and consequently of repeated sprint ability than short intermittent training.
34

O papel de gangliosídeos específicos como moduladores da liberação de mediadores de mastócitos / The role of mast cell specific gangliosides in modulating mediator release

Edismauro Garcia Freitas Filho 30 March 2015 (has links)
Os mastócitos são células multifuncionais do sistema imunológico que participam em diversos processos biológicos. As funções dos mastócitos estão diretamente relacionados com a sua ativação e, subsequente, liberação de mediadores químicos. Os eventos iniciais da ativação dos mastócitos e da transdução de sinais ocorrem em microdomínios lipídicos (lipid rafts) da membrana plasmática. Os gangliosídeos derivados do GD1b são constituintes dos lipid rafts de mastócitos de roedores. O intercruzamento destes gangliosídeos pelo mAb AA4, resulta na formação de agregados (caps) na superfície celular e promove uma ativação parcial dos mastócitos, sem que ocorra a desgranulação. A ativação é semelhante a observada quando os FcRIs são intercruzados por antígenos multivalentes ligados a IgEs, mas neste caso ocorre a desgranulação. O presente estudo tem como objetivo caracterizar o papel dos gangliosídeos derivados do GD1b na liberação de mediadores de mastócitos da linhagem RBL-2H3. O intercruzamento dos gangliosídeos derivados do GD1b resulta na ativação dos fatores de transcrição NFAT e NFB e esta ativação é mediada pela proteína quinase Syk. A ativação destes fatores de transcrição resulta na liberação de mediadores neo-sintetizados, tais como: TNF-, interleucina (IL)-4. Por outro lado, o intercruzamento dos gangliosídeos derivados de GD1b não induz a liberação dos mediadores neoformados como o leucotrieno B4 (LTB4) e o leucotrieno C4 (LTC4). A agregação dos gangliosídeos derivados do GD1b resulta na desorganização dos lipid rafts e na redistribuição de seus componentes, como demostrado pela análise proteômica. Estes dados mostraram proteínas capazes de desencadear uma ativação parcial dos mastócitos e proteínas reguladoras negativas da desgranulação estão up reguladas, enquanto que proteínas críticas para a transdução do sinal estão down reguladas. Os resultados obtidos neste trabalho demonstram que os gangliosídeos derivados do GD1b desempenham papel crucial na integridade dos lipid rafts modulando a ativação e liberação de mediadores de mastócitos. / Mast cells are immunoregulatory cells that participate in diverse biological events. The action of mast cells is directly related to their activation and subsequent mediator release. Early signal transduction events occur in lipid rafts in the plasma membrane. GD1b-derived gangliosides are known constituents of lipid rafts in rodent mast cells. The cross-linking of these gangliosides by mAb AA4 results in a partial activation of mast cells similar to that observed when FcRIs are cross-linked, but does not result in the mast cell degranulation. With time, the gangliosides bound to mAb AA4 cap on the cell surface. The present study aims to characterize the role of the rodent mast cell specific gangliosides derived from GD1b in mediator release from RBL-2H3 mast cells. Cross-linking the GD1b-derived gangliosides activated the transcription factors NFAT and NFB and this activation was mediated by Syk. The activation of theses transcription factors by cross-linked GD1b-derived gangliosides results in the release of the neo-synthesized mediators TNF- and interleukin (IL)-4. However, cross-linking GD1b-derived gangliosides did not stimulate release of the newly formed mediators leukotriene B4 (LTB4) and leukotriene C4 (LTC4). Capping of GD1b-derived gangliosides disorganized lipid rafts and resulted in a redistribution of lipid raft components. Proteomic analysis showed that proteins that trigger mast cell activation and negative regulatory proteins of degranulation are up regulated, whereas proteins critical for signal transduction are down regulated in mast cells where the gangliosides are capped. The results of this work demonstrate that the mast cell-specific GD1b-derived gangliosides are crucial in maintaining the functional integrity of the lipid rafts and modulate cell activation and subsequent mediator release from mast cells.
35

Mecanismos de ação da bradicinina na diferenciação neural in vitro / Mechanisms of bradykinin in neural differentiation

Micheli Mainardi Pillat 19 November 2013 (has links)
Durante o desenvolvimento do sistema nervoso, as células têm a tarefa de proliferar, migrar, diferenciar, morrer ou amadurecer de modo altamente preciso para formar estruturas complexas. Tal precisão é alcançada em decorrência da interação perfeita entre as células que se comunicam por meio de mensageiros químicos no ambiente extracelular. Nesse contexto, nosso grupo tem reportado o envolvimento da bradicinina (BK) em processos do desenvolvimento neural. Recentemente, observou-se que a BK desempenha um papel importante na determinação do destino neural, favorecendo a neurogênese em detrimento da gliogênese em diversos modelos de diferenciação, além de potencializar a migração celular observada no modelo de neuroesferas de rato (Trujillo et al, 2012). Essas descobertas motivaram, como objetivo geral dessa tese, a investigação dos mecanismos subjacentes à BK que determinam seus efeitos. Dessa forma, o principal modelo de diferenciação utilizado foi as células precursoras neurais (CPNs) isoladas do telencéfalo de embriões de camundongos. Estas células proliferam na presença dos fatores de crescimento (GFs) EGF + FGF2, mantendo-se multipotentes e formando as neuroesferas, ao passo que migram e diferenciam em neurônios e glias pela remoção desses GFs, com boa proximidade aos eventos do desenvolvimento do cortex in vivo. Como resultados do presente trabalho, observou-se, inicialmente, que a BK também influencia efetivamente na diferenciação neural no modelo de CPNs murinas. Ao término da diferenciação, observou-se que esta cinina favoreceu a migração e promoveu o enriquecimento neuronal, evidenciado pelo aumento da expressão das proteínas β3-Tubulina e MAP2. Constatou-se também, que se observa uma baixa taxa de proliferação ao término da diferenciação na presença de BK (Trujillo et al, 2012), em consequência da grande proporção de neurônios em cultura estimulada por esta cinina. Esta relação causal foi evidenciada pelo ensaio de incorporação de EdU e concomitante imuno-detecção dos marcadores β3-Tubulina, GFAP e Nestina. Fatores que promovem a neurogênese podem promovê-la suprimindo a proliferação celular em CPNs indiferenciadas, mais especificamente, alongando a fase G1 do ciclo celular que resulta na divisão de diferenciação. Assim, investigou-se também se a BK influencia nesse processo. Análises por citometria de fluxo demonstraram que esta cinina suprimiu a proliferação estimulada pelos GFs, levando ao acúmulo de células na fase G1 do ciclo celular. Esse acúmulo não provém do bloqueio do ciclo, uma vez que se observam grandes proporções de células nas fases subsequentes à G1, indicando que essa fase foi apenas prolongada pela BK e, assim, corroboraria no favorecimento da neurogênese. Outra face dos mecanismos adjacentes à BK para seus efeitos na diferenciação neural se refere às vias de sinalização disparadas por esta cinina. Observou-se que a BK induz a produção de AMPc por intermédio de proteínas G sensíveis à toxina pertussis (TP) (provavelmente através da subunidade βγ de proteínas Gi) e promove a mobilização de cálcio dos estoques intracelulares, evidenciando o envolvimento da família de proteínas Gq. Esses resultados sugerem que o receptor B2 de cinina acopla-se tanto às proteínas Gi quanto às proteínas Gq em CPNs. A exposição dessas células à BK também ativou as vias da PI3K/Akt e da MAPK p38, mas não influenciou na ativação de STAT3 e JNK. Destaca-se o potencial da rota da MAPK ERK como uma das principais cascatas responsáveis por decodificar sinais de mensageiros externos em respostas celulares. O tratamento com BK em CPNs ativou a ERK por tempo prolongado e estimulou sua translocação para o núcleo. O efeito de BK na glio- e neurogênese de CPNs foi dependente da atividade de ERK, porque o bloqueio farmacológico dessa enzima impediu esse efeito de BK. Por outro lado, o favorecimento da migração induzido por esta cinina foi dependente da atividade da p38, enquanto, o seu efeito antiproliferativo foi condicionado à atividade das suas duas MAPKs, ERK e p38. Além disso, a via da PI3K/Akt ativada por BK não influenciou nos três eventos avaliados. Finalmente, utilizou-se nessa tese uma abordagem reducionista da diferenciação, porém amplamente utilizada por estudos mecanísticos de neurogênese, as células PC12. Assim, observou-se que a BK também ativa a ERK por tempo prolongado e com translocação nuclear, sendo que tal forma de ativação dessa quinase é proposta na literatura como necessária e suficiente para induzir a neurogênese dessas células. Demonstrou-se ainda que o bloqueio apenas da ativação sustentada de ERK, pela inibição das atividades das PKCs clássicas, impede o favorecimento da neurogênese por BK em células PC12. Juntos, esses resultados contribuem para elucidação dos mecanismos de ação da BK na regulação da diferenciação neural, colaborando para melhor entender esse processo e prevendo possíveis aplicações em terapias de reparo neuronal em pacientes com doenças, por exemplo, de Parkinson, Alzheimer, Esclerose Múltipla e lesões isquêmicas. / During CNS development cells perform the task of proliferating, migrating, differentiating, dying or maturing in highly accurate patterns. Such accuracy is reached as a result of the perfect interaction among the cells that constantly communicate with each other through cell-cell contact or through chemical messengers present in the extracellular medium. In this context, our group has reported the involvement of bradykinin (BK) in neural differentiation of stem cell models (Trujillo et al, 2012). Recently, it has been observed that BK plays an important role in determining neural destination, favoring neurogenesis over gliogenesis in several models of differentiation, besides potentializing cell migration observed in the model of rat neurospheres. These discoveries have motivated, as the general objective of this thesis, the investigation of the mechanisms underlying BK-promoted effects on neural differentiation using neural precursor cells (NPCs) isolated from the telencephalon of mice embryos. These cells proliferate in the presence of growth factors (GFs) EGF + FGF2, remaining multipotent and forming neurospheres, while they migrate and differentiate in neurons and glias following removal of these GFs, resembling in simplified conditions events of the development of the cortex in vivo. As results of the present thesis, it was initially observed that BK also effectively influences neural differentiation fate of the mouse NPC model. This kinin favored migration and promoted neuronal enrichment, evidenced by increased expression of β3-Tubulin and MAP2 marker proteins. Moreover, proliferation rates were largely decreased following differentiation in the presence of BK (Trujillo et al, 2012), due to the large proportion of neurons in the culture stimulated by this kinin. This causal relation was evidenced by the EdU incorporation assay and the concomitant immunodetection rates of β3- Tubulin, GFAP and Nestin markers. Factors which promote neurogenesis can promote it by suppressing cell proliferation in undifferentiated NPCs, more specifically, prolonging the G1 phase of the cell cycle that result in the division of differentiation. Thus, it was further investigated whether BK influences this process. Flow cytometry analyses showed that this kinin suppressed the proliferation stimulated by GFs, resulting in the accumulation of cells in the G1 phase of the cell cycle. This accumulation is not caused by a cycle block, since wide proportions of cells are observed in phases subsequent to the G1, indicating that this phase was only prolonged by BK, thus corroborating for favoring neurogenesis. Another aspect of the mechanisms adjacent to BK for its effects on neural differentiation refers to the signaling pathways triggered by this kinin. Here, we show that the kinin B2 receptor couples to both Gi and Gq proteins in NPCs. BK induced the production of intracellular cAMP by activation of G proteins sensitive to pertussis toxin (PT) (probably through βγ subunit of Gi proteins) and promoted the mobilization of calcium from intracellular stocks, demonstrating the involvement of YM-254890-sensitive Gq proteins. Exposure of these cells to BK also activated PI3K/Akt and MAPK p38 pathways, but did not affect the activation of STAT3 and JNK. It is important to note the potential MAPK-ERK route as one of the main cascades responsible for decoding signals from external messengers into cellular responses. NPC treatment with BK activated ERK for prolonged time and stimulated its translocation into the nucleus. The effect of BK on glio- and neurogenesis of NPCs depended plainly on ERK activity, because the pharmacological blockade of this enzyme prevented the BK-exerted effects. On the other hand, the favoring of migration induced by this kinin was dependent on p38 activity, while its antiproliferative effect was conditioned to the activity of both the MAPKs ERK and p38. In addition, the PI3K/Akt pathway activated by BK did not affect any of the three evaluated events. Finally, we used in this thesis a reductionist approach of differentiation based on the use of PC12 cells, which has been widely used for mechanistic studies of neurogenesis. Thus, it was observed that BK also activated ERK for prolonged time and with nuclear translocation, considering that such form of kinase activation is proposed in the literature as necessary and sufficient to induce neurogenesis in these cells. This study also demonstrated that blockade only of the sustained ERK activation, through the inhibition of the activity of classic PKCs, prevents the favoring of neurogenesis by BK in PC12 cells. Together, these results compose novel mechanisms of action of BK on events of neural development in vitro, contributing to the better understanding of this process and foreseeing possible applications in the future for neuronal repair strategies
36

Caracterização do efeito da crotoxina sobre a funcionalidade dos neutrófilos da medula óssea / Characterization of the effect of crotoxin on the functionaly of bone marrow neutrophils

Tatiane Soares de Lima 10 August 2015 (has links)
Estudos anteriores demonstraram que a crotoxina (CTX), o principal componente do veneno de Crotalus durissus terrifucus, apresenta ação anti-inflamatória, inibindo a migração celular e a atividade fagocítica de neutrófilos peritoneais. Esses efeitos inibitórios são prolongados, uma vez que podem ser observados até 14 dias após a administração de uma única dose dessa toxina. Considerando-se a vida média curta dos neutrófilos, é difícil explicar como a ação inibitória da CTX sobre os neutrófilos circulantes e peritoneais persiste por períodos prolongados após a administração de uma única dose da toxina. Dessa forma, o objetivo desse estudo foi avaliar o efeito in vitro e in vivo da CTX sobre a atividade funcional dos neutrófilos da medula óssea de camundongos e alguns dos mecanismos moleculares envolvidos na ação inibitória da CTX sobre as funções avaliadas. Para os ensaios in vitro, os neutrófilos foram incubados com a CTX (0,08 μg/mL), por 1 ou 24 horas. Para os ensaios in vivo, os animais foram pré-tratados com uma única administração de CTX (44 mg/kg), 1 dia antes do isolamento das células. Uma vez obtidos os neutrófilos, os seguintes parâmetros funcionais foram avaliados: quimiotaxia, adesão à fibronectina, fagocitose, produção de espécies reativas do oxigênio e desgranulação. Os resultados obtidos demonstraram que a CTX, in vitro e in vivo, inibiu os processos de quimiotaxia, adesão à fibronectina e fagocitose de partículas opsonizadas, entretanto não alterou a produção de espécies reativas do oxigênio ou a desgranulação em neutrófilos da medula óssea. Esses resultados demonstram que a CTX induz efeito inibitório sobre a funcionalidade dos neutrófilos da medula óssea, particularmente sobre funções associadas à polimerização de actina e consequente reorganização do citoesqueleto. Ainda, com o objetivo de elucidar os possíveis mecanismos envolvidos neste efeito inibitório, foram realizados ensaios para a análise da expressão do receptor CR3, bem como para a avaliação da expressão total e da atividade de proteínas de sinalização intracelular envolvidas na polimerização de actina nos neutrófilos. Os resultados obtidos mostraram que a CTX inibiu a expressão de ambas as subunidades (CD11b e CD18) do receptor CR3, bem como inibiu a atividade de Syk, Vav1, Cdc42, Rac1 e RhoA e a expressão da subunidade 1B do complexo Arp2/3. Em conjunto, os resultados desse estudo mostraram que a CTX inibe a funcionalidade dos neutrófilos da medula óssea e que essa ação está associada à inibição do receptor CR3, bem como à inibição da atividade de Syk e de suas proteínas downstream, o que resulta na redução da formação de filamentos de F-actina. Os resultados desse estudo comprovam a hipótese de que ação inibitória prolongada da CTX sobre a atividade dos neutrófilos circulantes e peritoneais está associada a alterações funcionais dos neutrófilos da medula óssea. Ainda, considerando-se a participação central dessas células na resposta inflamatória aguda, esse estudo contribui para a elucidação do efeito anti-inflamatório prolongado da CTX / Previous studies demonstrated that crotoxin (CTX), the main component of Crotalus durissus terrificus venom, presents anti-inflammatory properties, inhibiting cell migration and the phagocytic activity of peritoneal neutrophils. These inhibitory effects are long-lasting, since it can be observed up to 14 days after a single administration of this toxin. Considering the short half-life of neutrophils, it is difficult to explain how the inhibitory effect of CTX on circulating and peritoneal neutrophils persists for long periods after a single injection of this toxin. Thus, the aim of this study was to evaluate the in vitro and in vivo effect of CTX on the functionality of bone marrow neutrophils from mice and some of the molecular mechanisms involved on the inhibitory effect of CTX on these functions. For in vitro assays, neutrophils were incubated with CTX (0,08 μg/mL), for 1 or 24 hours. For in vivo assays, the animals were pretreated with a single administration of CTX (44 mg/kg), 1 day before the isolation of cells. Once obtained the neutrophils, the following functional parameters were evaluated: chemotaxis, adhesion to fibronectin, phagocytosis, reactive oxygen species production and degranulation. The results demonstrated that CTX, in vitro and in vivo, inhibited the processes of chemotaxis, adhesion to fibronection and phagocytosis of opsonized particles, however, it did not alter the reactive oxygen species production and degranulation. These results showed that CTX induces an inhibitory effect on the functionality of bone marrow neutrophils, particularly on functions that depend on actin polymerization and cytoskeleton rearrangement. Furthermore, to elucidate some possible mechanisms involved on this inhibitory effect, assays to analyze the expression of the receptor CR3, as well as, assays to analyze the total expression and activity of signaling proteins involved on actin polymerization were done. The results showed that CTX inhibited both subunits of CR3 (CD11b and CD18) and the activity of Syk, Vav1, Cdc42, Rac1 and RhoA and the expression of the subunit 1B from Arp2/3. Together, the results presented herein demonstrate that CTX inhibits the functionally of bone marrow neutrophils and that this effect is associated to the inhibition of CR3 receptor and inhibition of the activity of Syk and its downstream signaling proteins, which results in the decrease of F-actin. The results prove the hypothesis that the long-lasting inhibitory effect of CTX on the activity of circulating and peritoneal neutrophils is associated to functional modifications of bone marrow neutrophils. Besides, considering the central role of these cells on the inflammatory response, this study contributes to the better understanding of the long-lasting anti-inflammatory effect of CTX
37

Efeito do treinamento concorrente na expressão gênica e protéica associadas à hipertrofia muscular / Effect of concurrent training on gene and protein expression associated with skeletal muscle hypertrophy

Eduardo Oliveira de Souza 12 March 2010 (has links)
Diversos atletas e praticantes de atividades físicas incorporam em suas rotinas de treinamento, exercícios aeróbios e de força motora simultaneamente. Contudo, essa combinação conhecida como treinamento concorrente (TC) tem demonstrado uma atenuação da resposta adaptativa da força e hipertrofia muscular. O presente estudo analisou se alguns genes e proteínas envolvidos na resposta hipertrófica e na biogênse mitocondrial do músculo esquelético poderiam explicar a atenuação da resposta adaptativa com o TC. Trinta e sete sujeitos foram divididos nos grupos: controle (C), aeróbio (TA), força (TF) e concorrente (TC) e submetidos a oito semanas de treinamento. Os resultados significantes foram: aumento na força dinâmica máxima de 270,3 (±45,5) para 320,3 (±57,0) Kg para o TF e de 268,4 (±47,6) para 315,7 (±63,5) para o TC; área de secção transversa do quadríceps de 8332,4 (±817,5) mm2 para 8849,5 (±893,3) mm2 para o TF e de 8340,8 (±1000,0) mm2 para 8996,8 (±919,5 )mm2 para o TC; o gene da mTOR demonstrou aumento significante de 1,01 (±0,10) U.A para 1,44 (±0,17) U.A no TF e redução de 1,01 (±0,15) para 0,536 (± 0,25) U.A da p70S6K1 no TC; a expressão total da proteína p70S6K1 demonstrou aumentou no grupo TC em relação ao C (1,1 (±0,2) U.A vs 0,8 (±0,3) U.A), a fosforilação da Akt no resíduo ser473 e da p70S6K1no resíduo thr389 aumentou somente no TF em relação ao C (1,3 (±0,2) U.A vs 0,9 (±0,1) U.A e 1,3 (±0,4) vs 0,8 (±0,3) U.A, respectivamente). O grupo TF e TC demonstraram adaptações similares nas variáveis de força e hipertrofia muscular apesar de algumas diferenças na resposta molecular. Esses achados indicam que na fase inicial do TC as diferenças na adaptação molecular não refletem em alterações na força e hipertrofia muscular quando comparadas ao TF / Many athletes and individuals involved in physical training perform strength and endurance exercises in the same training unit. However, this combination, referred as concurrent training (CT), has shown to blunt strength and skeletal muscle growth responses. This study investigated whether some genes and proteins associated with muscle growth and mitochondrial biogenesis may explain the decreased adaptive response to CT. Thirty seven participants were divided into four groups: control (C), endurance (TA), strength (TF) and concurrent (TC) and submitted to eight weeks of training. Significant results were found in the following variables from pre to post training: maximum dynamic strength - TF from 270,3 (±45,5) to 320,3 (±57,0) Kg and TC from 268,4 (±47,6) to 315,7 (±63,5); quadriceps cross sectional area (CSA) - TF from 8332,4 (±817,5) mm2 to 8849,5 (±893,3) mm2, TC from 8340,8 (±1000,0) mm2 to 8996,8 (±919,5)mm2; mTOR gene expression increased significantly post-training only for the TF (1,01 (±0,10) A.U to 1,44 (±0,17) A.U) and p70S6K1 was significantly reduced post-training (1,01 (±0,15) to 0,536 (± 0,25) A.U) for the TC; p70S6K1 total protein content was significantly greater after TC when compared with C (1,1 (±0,2) U.A vs 0,8 (±0,3)) and phosphorylation of both Akt at ser473 and p70S6K1 at thr389 increased only after TF compared with C (1,3 (±0,2) U.A vs 0,9 (±0,1) U.A and 1,3 (±0,4) vs 0,8 (±0,3) U.A, respectively). TF and TC groups had similar improvements in muscle strength and hypertrophy, besides some differences in the molecular responses. These differences at the molecular level in early phases of the TC do not blunt muscle strength and hypertrophy adaptations compared with the TF
38

Étude des voies de signalisation impliquées dans le contrôle de l’expression de SMN dans des modèles murins d’Amyotrophie Spinale Infantile / Study of Signaling pathways involved in SMN gene expression in Spinal Muscular Atrophy-like mouse models

Branchu, Julien 12 December 2012 (has links)
L'amyotrophie spinale infantile (SMA) est une maladie génétique autosomique récessive de l'enfant pour laquelle aucun traitement efficace n'existe. La SMA est caractérisée par la perte spécifique des motoneurones spinaux conduisant à une faiblesse musculaire sévère. Le décès des patients survient lorsque les muscles vitaux sont touchés. Cette maladie est causée par la mutation du gène Survival of Motor Neuron 1 (Smn1) conduisant à une diminution importante de l’expression de la protéine Survival of Motor Neuron (SMN). Tous les patients possèdent un ou plusieurs gènes copie de Smn1, le gène Smn2. Ces copies modulent la sévérité de la maladie en produisant une faible quantité de transcrits SMN complets, en particulier possédant l’exon 7, un exon alternatif qui code pour un domaine important pour que la protéine SMN soit fonctionnelle et stable. Des résultats récents, obtenus au laboratoire, indiquent que l'exercice physique retarde la mort des motoneurones, conduit à une augmentation du taux de maturation postnatale des unités motrices et déclenche l’expression du gène Smn2 chez des souris mimant la SMA de type II. Les premières données moléculaires suggèrent que les effets de l'exercice physique pourraient être relayés par la signalisation dépendante 1) des récepteurs au NMDA (Biondi et coll., J Neurosci, 2008) et/ou 2) du récepteur à IGF-1. Dans notre étude, nous avons d’abord testé les effets de l’activation directe des récepteurs au NMDA (NMDAR) dans un contexte de SMA. Nous montrons qu’une activation adéquate de ces récepteurs dans plusieurs modèles souris mimant les SMA sévères accélère la maturation postnatale des unités motrices, limite l'apoptose dans la moelle épinière et active l’expression du gène Smn2 favorisant l'expression de la protéine SMN. Ces effets bénéfiques sont dépendants du niveau d’activation des NMDARs et suggèrent que l'accélération de la maturation postnatale des unités motrices, induite par le NMDA, est indépendante du niveau d’expression de la protéine SMN. De manière importante, l’activation pharmacologique des NMDARs augmente fortement la durée de vie de deux modèles différents de souris mimant la SMA de type sévère. L'analyse des cascades de signalisation intracellulaire a révélé une altération inattendue des profils d’activation des voies de signalisation ERK et AKT/CREB, qui se rééquilibrent quand les NMDARs sont activés (Branchu et coll., J Neurosci, 2010).Comme la kinase ERK est constitutivement suractivée dans la moelle épinière des souris mimant la SMA, nous avons ensuite examiné son rôle potentiel dans la régulation de l'expression des gènes Smn2. Nous avons démontré que l'inhibition pharmacologique de la voie de signalisation MEK/ERK/Elk-1, notamment avec un médicament anti-cancéreux actuellement en essai clinique de phase 2, est bénéfique pour les souris mimant la SMA de type I. Nous avons identifié une relation croisée entre les voies de signalisation ERK et AKT impliquant la modulation, calcium-dépendante, de l'activité CaMKII. Ainsi, l'inhibition pharmacologique de ERK durant la phase symptomatique de la maladie chez ces souris, entraîne l'activation de la voie CaMKII/AKT/CREB et conduit à une augmentation significative de l’expression de la protéine SMN dans les motoneurones suite à une augmentation de la transcription du gène Smn2. Ces modifications sont corrélées avec une augmentation remarquable de la durée de vie et de la mobilité des souris et une neuroprotection des motoneurones spinaux. De plus, l’inhibition de ERK dans des cellules musculaires différenciées provenant de patients atteints de SMA de type II induit également une augmentation de l’activité de la voie AKT/CREB et de l’expression de SMN (Branchu et coll., J Neurosci, en révision positive). Enfin, nous avons montré que l'exercice physique est capable de diminuer l'expression du récepteur à l'IGF-1 (IGF-1R), qui est surexprimé dans la moelle épinière des souris mimant la SMA sévère... / Spinal muscular atrophy (SMA) is a severe autosomal recessive disease in childhood for which no efficient therapy is currently available. SMA is characterized by the specific loss of spinal motor neurons leading to a severe muscular weakness and death when vital muscles are affected. This disease is caused by mutation of the survival of motor neuron 1 (Smn1) gene leading to a deficiency of the Survival of Motor Neuron (SMN) protein expression. All patients retain one or more copies of the Smn2 gene, which modulates the disease severity by allowing a small amount of full-length SMN transcripts and stable SMN protein to be produced. Recent results in our laboratory indicate that physical exercise delays motor neuron death, leads to an increase in the motor-units postnatal maturation rate and trigger Smn2 gene expression in motor neurons. Furthermore, on the one hand, exercise is capable of specifically enhancing the expression of the gene encoding NR2A, the major activating subunit of the NMDA receptor in motor neurons. This subunit is known to be dramatically down-regulated in the spinal cord of severe SMA-like mice. Accordingly, inhibiting NMDA-receptor activity abolishes the exercise-induced effects on muscle development, motor neuron protection and life span gain (Biondi et al., J Neurosci, 2008). Thus, we tried to restore NMDA-receptor function as a therapeutic approach to SMA treatment. We demonstrated that an adequate NMDA receptor activation in severe SMA-like mouse model significantly accelerated motor-unit postnatal maturation, counteracted apoptosis in the spinal cord, and induced a marked increase in SMN expression resulting from a modification of Smn2 gene transcription pattern. These beneficial effects are dependent on the level of NMDA receptor activation since a treatment with high doses of NMDA led to an acceleration of the motor unit maturation but favored the apoptotic process and decreased SMN expression. Thus, these results suggest that the NMDA-induced acceleration of motor-unit postnatal maturation occurred independently of SMN. The NMDA receptor activating treatment strongly extended the life span in two different severe SMA-like mouse models. The analysis of the intracellular signaling cascades that lay downstream the activated NMDA receptor revealed an unexpected competition between the MEK/ERK/Elk-1 and the AKT/CREB signaling pathways for Smn2 gene regulation. Actually, the reactivation of the AKT/CREB pathway, thought calcium influx and the phosphorylation of CaMKII, opposed to MEK/ERK/Elk-1 inhibition, induces an enhanced SMN expression (Branchu et al., J Neurosci, 2010). On the other hand, exercise is capable of strongly decreasing the expression of IGF-1 receptor (IGF-1R); which is over-expressed in the spinal cord of severe SMA-like mice. We report that this reduction is also correlated with a reactivation of the AKT/CREB pathway and a MEK/ERK/Elk-1 inhibition. Therefore we generated an IGF-1R+/- SMA-like mouse model to investigate the functional link between IGF-1R expression level and the intracellular signaling pathway triggered in SMA spinal cord. We provided the first evidence that reducing the IGF-1R expression level is neuroprotective for SMA motor neurons, accelerates motor-unit postnatal maturation and leads to a remarkable increase in SMN expression and lifespan. The analysis of the intracellular signaling cascades revealed the same competition for Smn2 gene regulation. However, the activation of AKT/CREB is calcium-independent. In addition, we showed a drastic reduction of STAT3 phosphorylation and SOCS-1 and -3 expressions, which are over-expressed in SMA spinal cord and known to positively modulate ERK phosphorylation and negatively AKT (Data not published). Taken together all these data suggest new perspectives to therapeutic strategy, based on specific pharmacological correction, for SMA...
39

Exercice physique et progression du cancer de la prostate : effets combinés avec la prise d’antioxydants naturels ou la radiothérapie externe : identification de voies de signalisation redox-dépendantes / Physical exercise and prostate cancer progression : combined effects with natural antioxidant intake or external radiotherapy : identification of redox-dependant signaling pathways

Guéritat, Jordan 10 April 2015 (has links)
Le cancer de la prostate est un problème de santé publique majeur. L’exercice physique régulier fait désormais partie des moyens bien décrits pour améliorer la qualité de vie des patients atteints de cancer. Une activité physique quotidienne est donc recommandée pendant et après le traitement. Toutefois, aucune étude ne s’est intéressée aux interactions potentielles entre l’exercice physique, la consommation d’antioxydants et la radiothérapie. L’absence de connaissances sur les mécanismes moléculaires associés à ces stratégies connues pour moduler le stress oxydant, un facteur crucial dans l’évolution de la carcinogenèse prostatique, soulève aujourd’hui une question majeure : l’exercice physique influence-t-il la progression tumorale ? Les objectifs de ce travail de thèse étaient de déterminer les effets de l’exercice physique, combinée ou non à d’autres stratégies, sur la progression du cancer de la prostate et d’identifier des mécanismes moléculaires notamment redox-sensibles impliqués dans ces effets. En s’appuyant sur différentes études in vitro et in vivo, nos travaux ont mis en évidence que l’exercice physique prévient la progression du cancer de la prostate via la régulation du statut redox et de voies de signalisation redox-dépendantes, ou via une modulation de la cholestérolémie ou encore du profil d’expression des miRNAs. Nos travaux démontrent également que l’exercice physique associé à la prise d’antioxydants alimentaires inhibe les effets antiprolifératifs de ces stratégies isolées, et inversement, que l’exercice physique potentialise l’efficacité de la radiothérapie. / Prostate cancer is a major public health problem. It has now been widely recognized that regular physical exercise improves the quality of life of cancer patients. Thirty minutes of physical activity a day is recommended during and after treatment. However, potential interactions of physical exercise, dietary antioxidant intake and radiotherapy have not yet been studied. The lack of knowledge on molecular mechanisms associated with these strategies known to modulate oxidative stress, a key factor in prostate cancer evolution, raises a question: does physical exercise influence the efficiency of patient management and tumor evolution? The objectives of this work was to determine the effects of physical exercise, combined or not with others strategies, on prostate cancer progression and to identify redox sensitive-molecular mechanisms involved in these effects. We used different in vitro and in vivo approaches to achieve these aims. Our researches underline the essential role of physical exercise in prevention of prostate tumor progression, through a redox state and signaling pathways regulation, but also through a modulation of cholesterol levels or miRNA expression profiles. We also demonstrate that physical exercise associated to dietary antioxidant consumption limits anti-proliferative effects of these isolated treatments. Inversely, we reported that regular physical exercise enhances radiotherapy efficiency
40

Radiation sensitivity assay with a panel of patient-derived spheroids of small cell carcinoma of the cervix / 子宮頸部小細胞癌の患者由来スフェロイドパネルを用いた放射線感受性試験

Nakajima, Aya 23 March 2015 (has links)
京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第18869号 / 医博第3980号 / 新制||医||1008(附属図書館) / 31820 / 京都大学大学院医学研究科医学専攻 / (主査)教授 武田 俊一, 教授 小西 郁生, 教授 小松 賢志 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

Page generated in 0.0859 seconds